Weekly Vitals: Former Medtronic CEO on the Move, Five Ways to Support FDA Reform, and More

Some people just aren't suited for retirement. Former Medtronic CEO William Hawkins will come out of a short-lived retirement to join Georgia-based medical device company Immucor Inc. as CEO next week. "He knows this industry, and he's a respected leader in the sector," Adam Levine, a partner at TPG, the private equity firm that owns Immucor, told the Minneapolis Star-Tribune. In other news, Luke Timmerman at Xconomy wrote a polarizing piece recommending five things that industry can do to support FDA reform. Among them are supporting an increase in the agency's budget and allowing full disclosure of FDA complete response letters. Read about this and other top stories of the week below.